Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Prepaid Assets (2016 - 2025)

Moleculin Biotech (MBRX) has 9 years of Prepaid Assets data on record, last reported at $554000.0 in Q4 2024.

  • For Q4 2024, Prepaid Assets fell 79.65% year-over-year to $554000.0; the TTM value through Dec 2024 reached $554000.0, down 79.65%, while the annual FY2024 figure was $554000.0, 79.65% down from the prior year.
  • Prepaid Assets reached $554000.0 in Q4 2024 per MBRX's latest filing, down from $2.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.3 million in Q2 2022 and bottomed at $257000.0 in Q3 2020.
  • Average Prepaid Assets over 5 years is $1.9 million, with a median of $2.0 million recorded in 2020.
  • Peak YoY movement for Prepaid Assets: skyrocketed 636.19% in 2021, then tumbled 79.65% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $2.0 million in 2020, then crashed by 70.91% to $589000.0 in 2021, then increased by 1.87% to $600000.0 in 2022, then skyrocketed by 353.83% to $2.7 million in 2023, then crashed by 79.65% to $554000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $554000.0 in Q4 2024, $2.2 million in Q3 2024, and $2.9 million in Q2 2024.